More precisely, osteolytic lesions of human prostate cancer show enriched pAKT levels in the tumor area and associated macrophages, whereas osteoblastic lesions were shown to possess higher phospho-signal transducer and activator of transcription 3 (pSTAT3) levels [104]. The gene discussed is STAT3; the disease is prostate cancer.